Provider review
AVArx review
A platform for compounded GLP-1s with one from-figure tied to nothing.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated October 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
GLP-1 care from $199, tied to no drug or plan length
Visit AVArxUnusually clear about which states need a live call or video; vague about price.
Price as published
AVArx
GLP-1 care from $199, tied to no drug or plan length
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
AVArx is a telehealth technology platform in California that connects you with independent licensed providers and pharmacy partners for compounded semaglutide or tirzepatide. Its most useful feature is transparency about the rules: it lists exactly which states require a live audio call and which require video before a prescription can be written, so you know what to expect before you start. The five-minute online visit leads to a provider decision, and if you are prescribed, a pharmacy partner ships the medication, with dose adjustments, refills and messaging afterward. The safety information for each drug is set out in full. Pricing is the weak spot. The only figure is a from-price for GLP-1 care in general, with no drug, dose or plan length attached, so you cannot tell what semaglutide or tirzepatide will cost. The pharmacy partners are not named, and there is no low-dose product. You can pause or cancel anytime.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want to know in advance whether your state needs a live visit
- You want full safety information before you start
- You want to be able to pause or cancel anytime
Look elsewhere if
- You want a price for a specific drug
- You want the pharmacy named
- You want a low-dose product
What it actually costs
Price as published
GLP-1 care from $199, tied to no drug or plan length
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. Compounded semaglutide and tirzepatide through a technology platform, with one from-figure for GLP-1 care attached to no drug. No low-dose product exists.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- It lists exactly which states require a live audio or video visit before prescribing
- Pause or cancel anytime
- The safety information for each molecule is set out in full
Pharmacy, labs and oversight
AVArx does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What AVArx publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
AVArx is a telehealth technology platform in Glendale, California, that connects you with independent US-licensed providers and licensed pharmacy partners for GLP-1 weight-loss care. After a five-minute online visit, a provider decides whether compounded semaglutide or tirzepatide is appropriate; a pharmacy partner ships it, with dose adjustments, refills and messaging afterward. The site is unusually specific about telehealth rules, listing the states that require a live audio call and those that require video before a prescription can be written. The only price is a from-figure for GLP-1 care in general. The pharmacy is not named, and no low-dose product is described.
The honest cons
The only price is a from-figure tied to no drug or plan length
- The pharmacy partners are not named
- AVArx is a platform, not a medical practice, so care runs through third parties
- No low-dose or microdose product is offered
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
AVArx is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way AVArx does. Both are partners: we may earn a commission if you start care through these links.
Partner
HealthRX
$190/mo sema · $239/mo tirz (monthly plan)
Standard plan, self-directed low dose
Partner
Sprout Health
$149 sema · $199 tirz
Standard plan, self-directed low dose
FDA warning letter · Sprout Health · September 2025 · addressed to Sprout Health Partners LLC dba Sprout Health. Details in our review.
Where this sits
#434 of 548
Ordered with the companies that pay us first, and AVArx is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- Is compounded GLP-1 safe?
- What the evidence actually shows
- Low dose vs full dose
- The true annual cost of a plan
- Titration planner
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Bodybuilding Health+
$179/mo sema · $209/mo tirz
- Vs median
- $4/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Bodybuilding Health+ review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.